39 defence-tech companies are waiting to list. Their combined funding: $113 billion. And for the first time, pension capital and sovereign wealth funds are part of the equation — not as observers, as buyers.
Defence tech is transitioning from a niche venture capital category to an institutional asset class: the IPO pipeline of 39 pre-IPO companies and 15 S-1 filings gives pension and sovereign capital a liquid entry point that did not exist 24 months ago.
Lockheed Martin Ventures' expansion to a $1 billion fund and Keen Venture Partners' €150 million European defence fund, backed by the European Investment Fund and pension fund PME, signal structural capital formation, not a cyclical spike.
The result is a self-reinforcing cycle: more institutional capital drives larger later-stage rounds, which produces more IPO-ready companies, which attracts more institutional allocations.
In 2023, a dual-use robotics founder told VC Boom he had pitched 34 investors before finding one who understood defence procurement cycles. Eighteen months and one seed round later, the same founder could choose among dedicated defence-native funds, prime contractor corporate venture arms, and generalist firms that quietly added "national security" to their thesis after watching Anduril's exit multiples.
The change is not incremental. It is structural.
Defence-tech capital formation
Across 78 tracked companies. 39 are pre-IPO. 15 have filed S-1s. · TechStackIPO, Jul 2026
Venture capital deployment
Nearly triple the $10.7 billion recorded in 2020. The trajectory is a straight line. · S&P Global Market Intelligence, Mar 2026
What is driving the IPO wave
Three forces are colliding to produce a pipeline that investment banks have not seen since the late 1990s defence consolidation cycle.
The first is geopolitical. NATO defence budgets have expanded beyond the 2% commitment baseline, with several members now at 3% or higher. The proposed US FY2027 defence budget of $1.5 trillion represents a 44% increase (the largest since the Korean War), with $13.4 billion specifically earmarked for autonomous systems. This is not discretionary spending. It is a multi-decade procurement cycle backed by national security imperatives that survive election cycles.
The second is procurement reform. The FORGED and SPEED Acts, proposed within the FY2026 National Defense Authorization Act, are designed to loosen acquisition red tape and prioritise rapid procurement from commercial technology companies. The Pentagon's Office of Strategic Capital now provides direct loans and guarantees to defence startups. The SBIC Critical Technologies Initiative licenses billions in fund capacity for venture capital and private equity managers targeting Department of Defense-priority technologies. These mechanisms did not exist five years ago. They are creating a pipeline that funnels commercial innovation directly into defence procurement. That pipeline produces companies with the revenue visibility and contract backlog that public markets require.
The third is the Palantir precedent. PLTR's 10× run since 2023 validated the defence-tech IPO playbook. Public investors who missed Palantir are now actively scanning for the next pure-play defence software company. Anduril, Shield AI, and Scale AI are the most frequently cited candidates, but the pipeline runs deeper — HawkEye 360 successfully completed their NYSE IPO in May 2026, raising $416M, AEVEX Aerospace went public the same month, and Arctic Wolf completed its IPO in July 2026.
What is changing
The old objections to defence-tech as an asset class are falling away, one by one.
The ESG constraint that kept pension funds and university endowments at a distance has weakened substantially. The shift began in Europe, where the European Investment Fund launched a €175 million Defence Investment Programme in 2026 and committed €40 million to Keen Venture Partners' European defence and security fund alongside Dutch pension fund PME. In Canada, a BC pension fund backed Dominion Dynamics' $21 million fundraise, the largest early-stage defence round in the country's history. In Finland, Ilmarinen committed €15 million to Reaktor Group's IPO as a cornerstone investor.
The revenue-visibility objection, that defence companies lack the predictable recurring revenue that institutional investors demand, is also losing force. Multi-year procurement contracts, programme of record designations, and the shift toward software-defined systems have created annuity-like revenue streams that were absent in the era of fixed-price hardware development contracts. Anduril reported approximately $2.2 billion in revenue for 2025, with a backlog that extends across multiple budget cycles. Shield AI's Hivemind autonomous pilot software is deployed across US Marine Corps and special operations platforms, generating recurring integration and maintenance revenue.
The single greatest change, however, is the emergence of dedicated institutional infrastructure. Defence-tech is no longer accessed through a handful of specialist venture firms. Lockheed Martin Ventures expanded to $1 billion, the largest CVC fund in the sector. Keen Venture Partners closed the first tranche of Europe's largest defence-tech venture fund at €150 million. And on the public side, WisdomTree launched a Europe Defence UCITS ETF, giving retail and institutional investors a diversified vehicle for defence equity exposure.
What is new: pension and sovereign capital enters
This is the development that separates 2026 from every prior cycle. Institutional capital is no longer observing defence-tech from a distance. It is writing cheques.
The mechanisms vary by geography and mandate. Sovereign wealth funds — managing approximately $12.3 trillion collectively — have shifted their technology allocations from 8% to 22% of portfolios over five years, according to an IE University report. Gulf state funds (Mubadala, PIF, QIA) have deployed over $180 billion into AI and computing infrastructure since 2022. Singapore's GIC and Temasek have directed approximately $95 billion toward semiconductor and deep-tech investments. These are not venture capital allocations. They are strategic portfolio tilts.
Pension capital is following a different path: through IPOs and pre-IPO placements. Reaktor Group's June 2026 listing on Nasdaq Helsinki saw Ilmarinen commit €15 million as a cornerstone investor, part of a €45 million institutional tranche that was oversubscribed. Keen Venture Partners' fund received €40 million from Dutch pension fund PME alongside the European Investment Fund. In Canada, BC pension capital backed Dominion Dynamics at the early stage.
The pattern is consistent across markets: institutional capital is entering defence-tech not through venture funds but through public listings and fund structures that match their liquidity and return requirements. The IPO pipeline, 39 pre-IPO companies with $113 billion in cumulative funding, is the conduit.
US versus Europe: two markets, one trend
The defence-tech IPO wave is global, but it is taking different forms on either side of the Atlantic.
The US market is defined by a small number of very large candidates. Anduril, valued at $60 billion in its most recent funding talks, is the most anticipated defence-tech IPO since Palantir. Scale AI has not filed an S-1 registration statement with the SEC and remains a private company, despite ongoing market speculation regarding its valuation. Shield AI, also S-1 filed at a $12.7 billion valuation, represents the autonomous systems vertical. SpaceX's confidential IPO filing in April 2026, at a reported $1.75 trillion valuation, would be the largest public offering in history. And it is fundamentally a defence and space company.
Europe's wave is broader and more fragmented. RENK and Exosens listed in 2024, TKMS in 2025. In 2026, Reaktor Group completed its Helsinki IPO at €210 million market capitalisation, and CSG (the European land systems manufacturer) represents the largest-ever pure-play defence IPO on the continent, according to WisdomTree. The European defence equity market is bifurcating between heavy industrial primes and high-growth technology businesses, two distinct investment propositions requiring different valuation frameworks.
WisdomTree's analysis describes 2026 as "the scaling of European defence equity markets into a mainstream institutional asset class." The language is significant coming from an asset manager, not a defence publication.
Anduril S-1 filing — Anduril's public filing will set valuation benchmarks for every other candidate in the pipeline.
SpaceX IPO completion — a potential $75 billion raise that would absorb substantial institutional allocation capacity and test the market's appetite for defence-linked equities.
European defence fund performance — the Keen Venture Partners fund and WisdomTree Defence ETF are early tests of whether institutional capital will commit to European defence-tech at scale, or whether the US market will continue to dominate.
Defence procurement reform velocity — the FORGED Act's progress through Congress and its equivalents in NATO member states determine how quickly the IPO pipeline refills after the current cohort lists.
As we wrote in July, defence prime CVC funds are expanding rapidly: Lockheed Martin Ventures grew to $1 billion, and prime contractors across the sector are now running venture arms that function as curated deal flow for institutional investors who lack defence domain expertise. The IPO pipeline is the next logical stage of the same cycle: CVC-backed startups that reach prime procurement status are maturing toward public listings, and institutional capital is following them there.
None of this guarantees that every candidate will find a receptive market. The post-IPO experience of CSG, as WisdomTree notes, "reminds us that the path from IPO to long-term value creation is rarely linear, particularly in a sector where sentiment can move faster than order books." Defence tech is becoming an institutional asset class. It is not becoming a safe one.
The difference is that now, institutional investors have a choice, and a pipeline to act on it.